Načítá se...
Neuroleptic malignant syndrome associated with the use of injection zuclopenthixol acetate
Zuclopenthixol is usually used in parental form to manage acute agitation and psychosis.[1] It has high affinity for dopamine D1 and D2 receptors. There are very few reports of Neuroleptic Malignant Syndrome (NMS) with use of zuclopenthixol monotherapy. In this case report, we present a 35 year old...
Uloženo v:
| Vydáno v: | Ind Psychiatry J |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wolters Kluwer - Medknow
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8188941/ https://ncbi.nlm.nih.gov/pubmed/34158726 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ipj.ipj_49_19 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|